| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Harte-Hanks (NASDAQ:HHS) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:02 PM.
Here's what investors need to know about the announcement.
Harte-Hanks missed estimated earnings by 55.56%, reporting an EPS of $0.08 versus an estimate of $0.18.
Revenue was down $6.77 million from the same period last year.
Last quarter the company missed on EPS by $0.04 which was followed by a 0.87% drop in the share price the next day.
Here's a look at Harte-Hanks's past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.20 | 0.20 | 0.10 | 0.40 |
| EPS Actual | 0.16 | -0.11 | 0.08 | 0.83 |
| Revenue Estimate | 48.97M | 50.55M | 52.20M | 50.90M |
| Revenue Actual | 47.76M | 47.12M | 54.78M | 53.89M |
To track all earnings releases for Harte-Hanks visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: HHS
